Literature DB >> 33753940

Extracellular vesicles in immunomodulation and tumor progression.

Carolyn Marar1,2,3, Bartholomew Starich1,4, Denis Wirtz5,6,7,8.   

Abstract

Extracellular vesicles have emerged as prominent regulators of the immune response during tumor progression. EVs contain a diverse repertoire of molecular cargo that plays a critical role in immunomodulation. Here, we identify the role of EVs as mediators of communication between cancer and immune cells. This expanded role of EVs may shed light on the mechanisms behind tumor progression and provide translational diagnostic and prognostic tools for immunologists.

Entities:  

Mesh:

Year:  2021        PMID: 33753940      PMCID: PMC9389600          DOI: 10.1038/s41590-021-00899-0

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


  166 in total

1.  Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection.

Authors:  Sanyukta Rana; Shijing Yue; Daniela Stadel; Margot Zöller
Journal:  Int J Biochem Cell Biol       Date:  2012-06-19       Impact factor: 5.085

2.  Exosomes from Thymic Stromal Lymphopoietin-Activated Dendritic Cells Promote Th2 Differentiation through the OX40 Ligand.

Authors:  Li Huang; Xinxing Zhang; Meijuan Wang; Zhengrong Chen; Yongdong Yan; Wenjing Gu; Jiahong Tan; Wujun Jiang; Wei Ji
Journal:  Pathobiology       Date:  2018-11-08       Impact factor: 4.342

3.  Novel MHC class I structures on exosomes.

Authors:  Sarah Lynch; Susana G Santos; Elaine C Campbell; Ailish M S Nimmo; Catherine Botting; Alan Prescott; Antony N Antoniou; Simon J Powis
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

4.  Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.

Authors:  Jessica Gobbo; Guillaume Marcion; Marine Cordonnier; Alexandre M M Dias; Nicolas Pernet; Arlette Hammann; Sarah Richaud; Hajare Mjahed; Nicolas Isambert; Victor Clausse; Cédric Rébé; Aurélie Bertaut; Vincent Goussot; Frédéric Lirussi; François Ghiringhelli; Aurélie de Thonel; Pierre Fumoleau; Renaud Seigneuric; Carmen Garrido
Journal:  J Natl Cancer Inst       Date:  2015-11-22       Impact factor: 13.506

5.  Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.

Authors:  Liya Zhu; Senthilkumar Kalimuthu; Prakash Gangadaran; Ji Min Oh; Ho Won Lee; Se Hwan Baek; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2017-07-07       Impact factor: 11.556

6.  Crosstalk between tongue carcinoma cells, extracellular vesicles, and immune cells in in vitro and in vivo models.

Authors:  Shady Adnan Awad; Katja Tuomainen; Ahmed Al-Samadi; Yue Zhao; Abdelhakim Salem; Mataleena Parikka; Tuula Salo
Journal:  Oncotarget       Date:  2017-05-10

7.  Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts.

Authors:  Daniel Torralba; Francesc Baixauli; Carolina Villarroya-Beltri; Irene Fernández-Delgado; Ana Latorre-Pellicer; Rebeca Acín-Pérez; Noa B Martín-Cófreces; Ángel Luis Jaso-Tamame; Salvador Iborra; Inmaculada Jorge; Gloria González-Aseguinolaza; Johan Garaude; Miguel Vicente-Manzanares; José Antonio Enríquez; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Nat Commun       Date:  2018-07-09       Impact factor: 14.919

8.  Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity.

Authors:  Yeonsun Hong; Yoon Kyoung Kim; Gi Beom Kim; Gi-Hoon Nam; Seong A Kim; Yoon Park; Yoosoo Yang; In-San Kim
Journal:  J Extracell Vesicles       Date:  2019-09-28

9.  Exosomes Derived From T Regulatory Cells Suppress CD8+ Cytotoxic T Lymphocyte Proliferation and Prolong Liver Allograft Survival.

Authors:  Liang Chen; Hanfei Huang; Weixin Zhang; Feifan Ding; Zhenlei Fan; Zhong Zeng
Journal:  Med Sci Monit       Date:  2019-07-01

10.  Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells.

Authors:  Sophie A Dusoswa; Sophie K Horrevorts; Martino Ambrosini; Hakan Kalay; Nanne J Paauw; Rienk Nieuwland; Michiel D Pegtel; Tom Würdinger; Yvette Van Kooyk; Juan J Garcia-Vallejo
Journal:  J Extracell Vesicles       Date:  2019-08-09
View more
  44 in total

1.  Advances in Microfluidics for the Implementation of Liquid Biopsy in Clinical Routine.

Authors:  Alexandra Teixeira; Adriana Carneiro; Paulina Piairo; Miguel Xavier; Alar Ainla; Cláudia Lopes; Maria Sousa-Silva; Armando Dias; Ana S Martins; Carolina Rodrigues; Ricardo Pereira; Liliana R Pires; Sara Abalde-Cela; Lorena Diéguez
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Blockade of exosome release alters HER2 trafficking to the plasma membrane and gives a boost to Trastuzumab.

Authors:  Leila Asef-Kabiri; Hamzeh Sarvnaz; Alireza Ghanavatinejad; Reza Hosseini; Fatemeh Rezayat; Nahid Eskandari; Mohammad Esmaeil Akbari
Journal:  Clin Transl Oncol       Date:  2022-08-26       Impact factor: 3.340

Review 3.  An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions.

Authors:  Miguel A Ortega; Oscar Fraile-Martinez; Cielo Garcia-Montero; Miguel Angel Alvarez-Mon; Ana Maria Gomez-Lahoz; Agustin Albillos; Guillermo Lahera; Javier Quintero; Jorge Monserrat; Luis G Guijarro; Melchor Alvarez-Mon
Journal:  Membranes (Basel)       Date:  2022-05-25

4.  HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors.

Authors:  Lei Guan; Bin Wu; Ting Li; Lynn A Beer; Gaurav Sharma; Mingyue Li; Chin Nien Lee; Shujing Liu; Changsong Yang; Lili Huang; Dennie T Frederick; Genevieve M Boland; Guangcan Shao; Tatyana M Svitkina; Kathy Q Cai; Fangping Chen; Meng-Qiu Dong; Gordon B Mills; Lynn M Schuchter; Giorgos C Karakousis; Tara C Mitchell; Keith T Flaherty; David W Speicher; Youhai H Chen; Meenhard Herlyn; Ravi K Amaravadi; Xiaowei Xu; Wei Guo
Journal:  Nat Commun       Date:  2022-07-14       Impact factor: 17.694

Review 5.  The Role of Extracellular Vesicles in Melanoma Progression.

Authors:  Evelyn Lattmann; Mitchell P Levesque
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

6.  NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment.

Authors:  Irene Bertolini; Michela Perego; Jagadish C Ghosh; Andrew V Kossenkov; Dario C Altieri
Journal:  Oncogene       Date:  2022-03-30       Impact factor: 8.756

Review 7.  Engineering complexity in human tissue models of cancer.

Authors:  Kacey Ronaldson-Bouchard; Ilaria Baldassarri; Daniel Naveed Tavakol; Pamela L Graney; Maria Samaritano; Elisa Cimetta; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2022-03-09       Impact factor: 17.873

Review 8.  Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy.

Authors:  Shaobo Ruan; Zachary Greenberg; Xiaoshu Pan; Pei Zhuang; Nina Erwin; Mei He
Journal:  Adv Healthc Mater       Date:  2021-07-01       Impact factor: 11.092

9.  Extracellular Vesicles as a Means of Viral Immune Evasion, CNS Invasion, and Glia-Induced Neurodegeneration.

Authors:  Miranda D Horn; Andrew G MacLean
Journal:  Front Cell Neurosci       Date:  2021-07-05       Impact factor: 5.505

10.  M1 Macrophage-Derived Nanovesicles Repolarize M2 Macrophages for Inhibiting the Development of Endometriosis.

Authors:  Qiuju Li; Ming Yuan; Xue Jiao; Yufei Huang; Jing Li; Dong Li; Miaomiao Ji; Guoyun Wang
Journal:  Front Immunol       Date:  2021-07-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.